Form 8-K - Current report:
SEC Accession No. 0001564590-21-017811
Filing Date
2021-04-06
Accepted
2021-04-06 16:13:04
Documents
4
Period of Report
2021-04-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abio-8k_20210402.htm 8-K 39487
2 EX-5.1 abio-ex51_7.htm EX-5.1 15828
3 EX-10.1 abio-ex101_6.htm EX-10.1 29986
4 GRAPHIC gaavqm1vj4rf000001.jpg GRAPHIC 33607
  Complete submission text file 0001564590-21-017811.txt   133148
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 21809314
SIC: 2835 In Vitro & In Vivo Diagnostic Substances